SSAB AB (publ) (STO:SSAB.A)
54.68
-0.50 (-0.91%)
Aug 6, 2025, 2:12 PM CET
Intra-Cellular Therapies Market Cap
SSAB AB has a market cap or net worth of 54.15 billion as of August 6, 2025. Its market cap has decreased by -7.19% in one year.
Market Cap
54.15B
Enterprise Value
43.30B
Revenue
99.14B
Ranking
n/a
PE Ratio
12.20
Stock Price
$54.68
Market Cap Chart
Since February 13, 1997, SSAB AB's market cap has increased from 15.15B to 54.15B, an increase of 257.43%. That is a compound annual growth rate of 4.57%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 4, 2025 | 54.44B | 23.52% |
Dec 30, 2024 | 44.08B | -43.45% |
Dec 29, 2023 | 77.94B | 37.58% |
Dec 30, 2022 | 56.65B | 15.50% |
Dec 30, 2021 | 49.05B | 75.74% |
Dec 30, 2020 | 27.91B | -13.16% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Svenska Cellulosa Aktiebolaget SCA | 86.10B |
Boliden AB | 84.74B |
Holmen AB | 56.94B |
HEXPOL AB | 28.48B |
Billerud AB | 20.58B |
Alleima AB | 17.14B |
Gränges AB | 13.95B |
Nordic Paper Holding AB | 3.03B |